Literature DB >> 36094606

Ferroptosis-Related Genes with Regard to CTLA-4 and Immune Infiltration in Hepatocellular Carcinoma.

Jiahao Xu1, Xing Wu1, Xiaoyan Wang2.   

Abstract

Comprehensive analysis of ferroptosis in Hepatocellular Carcinoma (HCC) and its relation to the tumor immune microenvironment are needed. Data included HCC in The Cancer Genome Atlas and International Cancer Genome Consortium. And two datasets from Gene Expression Omnibus (GEO) were used as the validation set. Based on the expression of ferroptosis-related genes, HCC patients were divided into two subtypes. Cluster 1 showed lower tumor grade, lower CTLA-4, and a more favorable prognosis than Cluster 2. Patients with higher SLC7A11 (50%) had a poorer prognosis in HCC. SLC7A11 is characterized by more NK CD56bright cells, less DC, and neuroactive ligand-receptor interaction and cytokine receptor interaction. Ferroptosis-related genes especially SLC7A11 might be a valuable prognostic factor in HCC.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CTLA-4; Ferroptosis; Hepatocellular carcinoma; Immune infiltration; SLC7A11

Year:  2022        PMID： 36094606     DOI： 10.1007/s10528-022-10279-4

Source DB:  PubMed          Journal:  Biochem Genet        ISSN： 0006-2928            Impact factor:   2.220


  31 in total

Review 1.  Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Authors:  Pierre G Coulie; Benoît J Van den Eynde; Pierre van der Bruggen; Thierry Boon
Journal:  Nat Rev Cancer       Date:  2014-02       Impact factor: 60.716

Review 2.  Ferroptosis Inhibition: Mechanisms and Opportunities.

Authors:  Jose Pedro Friedmann Angeli; Ron Shah; Derek A Pratt; Marcus Conrad
Journal:  Trends Pharmacol Sci       Date:  2017-03-28       Impact factor: 14.819

Review 3.  Dendritic Cells and Cancer Immunity.

Authors:  Alycia Gardner; Brian Ruffell
Journal:  Trends Immunol       Date:  2016-10-25       Impact factor: 16.687

4.  Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.

Authors:  Austin G Duffy; Susanna V Ulahannan; Oxana Makorova-Rusher; Osama Rahma; Heiner Wedemeyer; Drew Pratt; Jeremy L Davis; Marybeth S Hughes; Theo Heller; Mei ElGindi; Ashish Uppala; Firouzeh Korangy; David E Kleiner; William D Figg; David Venzon; Seth M Steinberg; Aradhana M Venkatesan; Venkatesh Krishnasamy; Nadine Abi-Jaoudeh; Elliot Levy; Brad J Wood; Tim F Greten
Journal:  J Hepatol       Date:  2016-11-02       Impact factor: 25.083

Review 5.  Targets for immunotherapy of liver cancer.

Authors:  Tim F Greten; Bruno Sangro
Journal:  J Hepatol       Date:  2017-09-18       Impact factor: 25.083

6.  Ferroptosis: an iron-dependent form of nonapoptotic cell death.

Authors:  Scott J Dixon; Kathryn M Lemberg; Michael R Lamprecht; Rachid Skouta; Eleina M Zaitsev; Caroline E Gleason; Darpan N Patel; Andras J Bauer; Alexandra M Cantley; Wan Seok Yang; Barclay Morrison; Brent R Stockwell
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

Review 7.  The PD-1 pathway in tolerance and autoimmunity.

Authors:  Loise M Francisco; Peter T Sage; Arlene H Sharpe
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

8.  Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.

Authors:  Anthony B El-Khoueiry; Bruno Sangro; Thomas Yau; Todd S Crocenzi; Masatoshi Kudo; Chiun Hsu; Tae-You Kim; Su-Pin Choo; Jörg Trojan; Theodore H Welling; Tim Meyer; Yoon-Koo Kang; Winnie Yeo; Akhil Chopra; Jeffrey Anderson; Christine Dela Cruz; Lixin Lang; Jaclyn Neely; Hao Tang; Homa B Dastani; Ignacio Melero
Journal:  Lancet       Date:  2017-04-20       Impact factor: 79.321

9.  M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.

Authors:  Gowri Rangaswamy Gunassekaran; Sri Murugan Poongkavithai Vadevoo; Moon-Chang Baek; Byungheon Lee
Journal:  Biomaterials       Date:  2021-09-17       Impact factor: 12.479

Review 10.  Ferroptosis: A New Strategy for Cancer Therapy.

Authors:  Yu Chen; Zhihua Fan; Shen Hu; Chengchao Lu; Yi Xiang; Shuzhi Liao
Journal:  Front Oncol       Date:  2022-02-16       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.